Catalio Strategy
Public Equities
Catalio Public Equities is a fundamental, equity long/short strategy investing in global healthcare equities across innovative drugs, devices, diagnostics and data.
Scroll
The strategy is a long-bias, bottom-up approach, focused on identifying mispriced risk across clinical/scientific, regulatory, intellectual property, new product launches and corporate events.
Long-bias
We believe that innovative healthcare skews higher in value over time and we position directionally long to take advantage of that opportunity.
Bottom-up approach
Our portfolio is built on stock-by-stock diligence supported by our experienced team of analysts and our world-class venture partner network.
Differentiated portfolio footprint
Our unique firm expertise gives us the confidence to invest effectively in a differentiated group of companies spanning multiple sub-sectors and a broad market cap range, diversifying our returns and allowing us to more effectively manage risk.
Long term experience
Our team is led by investment professionals with decades of experience in healthcare public equities, using a process honed across varied market cycles and investing environments.
